pubmed-article:10235125 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0032305 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0072600 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C1442757 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10235125 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10235125 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:10235125 | pubmed:dateCreated | 1999-5-26 | lld:pubmed |
pubmed-article:10235125 | pubmed:abstractText | The pathogenesis of Pneumocystis carinii pneumonia (PCP) suggests an important role for dysfunction of the pulmonary surfactant system in the hypoxemic respiratory insufficiency associated with this infection. Surfactant protein B (SP-B) is a hydrophobic protein shown to be essential for normal surfactant function in vivo. Therefore, we hypothesized that the inhibition of SP-B expression occurs during PCP, and we tested this hypothesis in two immunodeficient animal models. PCP was induced in C.B-17 scid/scid mice by intratracheal inoculation of P. carinii organisms. Infected lung homogenates, obtained at time points up to 6 weeks after inoculation, were analyzed for SP-B and mRNA content. When a comparison was made with uninfected scid controls, the densitometric quantitation of Western blots of lung homogenates demonstrated significant reductions in 8 kd SP-B in mice infected with P. carinii 4 weeks after inoculation (16% of the control value). Northern blot analysis showed a concomitant decrease in SP-B mRNA to 24% of the control level. The decrease in SP-B and mRNA levels in lung homogenates of infected mice was reflected in lower SP-B levels in the surfactant. An enzyme-linked immunosorbent assay for the SP-B level in surfactant prepared from bronchoalveolar lavage samples of infected scid mice demonstrated a significant reduction in alveolar SP-B content (45% of the control value). In contrast to the results with SP-B, neither the SP-A protein content nor the mRNA level was significantly altered by PCP infection. To confirm these observations, SP-B expression was studied in an additional animal model of PCP. The SP-B content of lung homogenates from BALB/c mice depleted of CD4+ T cells and infected with P. carinii was also reduced (51% of the control value). We conclude that P. carinii induces selective inhibition of the expression of SP-B in two mouse models of PCP and that this down-regulation is mediated at the level of mRNA expression. Therefore, an acquired deficiency of SP-B is likely to be an important contributor to the pathogenesis of hypoxemic respiratory failure that is observed in patients with PCP. | lld:pubmed |
pubmed-article:10235125 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:language | eng | lld:pubmed |
pubmed-article:10235125 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:10235125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10235125 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10235125 | pubmed:month | May | lld:pubmed |
pubmed-article:10235125 | pubmed:issn | 0022-2143 | lld:pubmed |
pubmed-article:10235125 | pubmed:author | pubmed-author:PrestonA MAM | lld:pubmed |
pubmed-article:10235125 | pubmed:author | pubmed-author:AtochinaE NEN | lld:pubmed |
pubmed-article:10235125 | pubmed:author | pubmed-author:BeersM FMF | lld:pubmed |
pubmed-article:10235125 | pubmed:author | pubmed-author:BeckJ MJM | lld:pubmed |
pubmed-article:10235125 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10235125 | pubmed:volume | 133 | lld:pubmed |
pubmed-article:10235125 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10235125 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10235125 | pubmed:pagination | 423-33 | lld:pubmed |
pubmed-article:10235125 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:meshHeading | pubmed-meshheading:10235125... | lld:pubmed |
pubmed-article:10235125 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10235125 | pubmed:articleTitle | Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. | lld:pubmed |
pubmed-article:10235125 | pubmed:affiliation | Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6068, USA. | lld:pubmed |
pubmed-article:10235125 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10235125 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235125 | lld:pubmed |